TrueBlue, Inc. (TBI) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$6.04
Price Target
$5.75
Target Range
$5.50 — $6.00
Analyst Rating
Buy
Forward P/E—
Trailing P/E-3.8x
Forward PEG—
Implied Growth+94.0%
Median Target$5.75
Analyst Spread8.7%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$6
-8.9%
Consensus
$6
-4.8%
Bull Case
$6
-0.7%
TBI Price Target Analysis
Updated May 6, 2026As of May 6, 2026, TrueBlue, Inc. (TBI) has a Wall Street consensus price target of $5.75, based on estimates from 10 covering analysts. With the stock currently trading at $6.04, this represents a potential downside of -4.8%. The company has a market capitalization of $182M.
Analyst price targets range from a low of $5.50 to a high of $6.00, representing a 9% spread in expectations. The median target of $5.75 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, TBI trades at a trailing P/E of -3.8x. Analysts expect EPS to grow +94.0% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Industrials stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+29.6%
Avg Forward P/E22.3x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 MANManpowerGroup Inc. | $1.4B | $29.64 | $37.86 | +27.7% | Hold | 8.1x | 29 |
 KFYKorn Ferry | $3.4B | $66.93 | $70.00 | +4.6% | Buy | 12.6x | 11 |
 KELYAKelly Services, Inc. | $346M | $9.82 | $15.00 | +52.7% | Buy | 11.1x | 5 |
 HSIIHeidrick & Struggles International, Inc. | $1.2B | $59.01 | $59.00 | -0.0% | Hold | 16.7x | 5 |
 ASGNASGN Incorporated | $895M | $20.96 | $37.60 | +79.4% | Hold | 5.8x | 13 |
 KFRCKforce Inc. | $802M | $43.87 | $71.00 | +61.8% | Hold | 18.2x | 10 |
 HCIHCI Group, Inc. | $2.0B | $154.78 | $126.50 | -18.3% | Buy | 9.3x | 14 |
 CCRNCross Country Healthcare, Inc. | $344M | $10.67 | $10.61 | -0.6% | Hold | 109.1x | 14 |
 NSPInsperity, Inc. | $1.1B | $28.58 | $48.60 | +70.0% | Hold | 13.3x | 8 |
 ADPAutomatic Data Processing, Inc. | $84.8B | $210.60 | $249.00 | +18.2% | Hold | 19.1x | 36 |
Upside Potential Comparison
ASGNNSPKFRCKELYAMANADPKFYHSIISee TBI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TBI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TBI vs SPIR
Side-by-side business, growth, and profitability comparison vs Spire Global, Inc..
Start ComparisonTBI — Frequently Asked Questions
Quick answers to the most common questions about buying TBI stock.
What is the TBI stock price target for 2026?
Wall Street's consensus price target for TBI is $5.75, -4.8% from its current price of $6.04. The below-market target from 10 analysts suggests limited near-term appreciation.
Is TBI a buy, sell, or hold?
TBI has a consensus rating of "Buy" based on 10 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $5.75 implies -4.8% downside from current levels.
Is TBI stock overvalued or undervalued?
TBI's current price is $6.04 with a consensus target of $5.75 (-4.8% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
How high can TBI stock go?
The most bullish Wall Street analyst has a price target of $6 for TBI, while the most conservative target is $5.5. The consensus of $5.75 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover TBI stock?
TBI is moderately covered, with 10 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 4 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the TBI stock forecast?
The 12-month TBI stock forecast based on 10 Wall Street analysts shows a consensus price target of $5.75, with estimates ranging from $5.5 (bear case) to $6 (bull case). The median consensus rating is "Buy".
Should I buy TBI stock?
Analysts are cautious on TBI, with 1 Sell ratings and a price target of $5.75 (-4.8% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do TBI price targets vary so much?
TBI analyst price targets range from $5.5 to $6, a 9% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $5.75 consensus represents the middle ground.